Abbott Laboratories Stock Pattern Recognition Ladder Bottom

ABT Stock

USD 108.03 -0.11 -0.10%

The pattern recognition module provides an execution environment for Ladder Bottom recognition and related indicators on Abbott Laboratories. The analysis highlights pattern recognition signals tied to momentum and continuation and frames technical signals with volatility and risk context.

Symbol

Recognition

The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was fourteen with a total number of output elements of forty-seven. The function did not return any valid pattern recognition events for the selected time horizon. The Ladder Bottom is a reversal pattern describing Abbott Laboratories bullish trend.

Abbott Laboratories Technical Analysis Modules

Most technical analysis of Abbott Laboratories help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Abbott from various momentum indicators to cycle indicators. When you analyze Abbott charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

	Cycle Indicators
	Math Operators
	Math Transform
	Momentum Indicators
	Overlap Studies
	Pattern Recognition
	Price Transform
	Statistic Functions
	Volatility Indicators
	Volume Indicators

Stock Overview, Methodology & Data Sources

The stock is currently undergoing a sell-off trend.Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. It employs 113000 people. This stock section frames Abbott Laboratories within its peer set and highlights how fundamentals align with price behavior. Current metrics include P/E of 24.14, P/B of 3.6, profit margin of 14.72%. Abbott Laboratories has a market cap of 187.72 B, P/E of 24.14, ROE of 12.96%.

Methodology

Unless otherwise specified, financial data for Abbott Laboratories is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Abbott (USA Stocks:ABT) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.

Analyst Sources

Abbott Laboratories is covered by 28 analysts. 14 analysts have submitted revenue and/or earnings estimates that may be incorporated into Macroaxis consensus inputs where available. Representative analyst firms may include Bernstein Research, Deutsche Bank, Morgan Stanley, BMO Capital Markets, Guggenheim Securities, Jefferies, Goldman Sachs, Evercore ISI, Raymond James, among others. Updates may occur throughout the day.

This content is curated and reviewed by:

Ellen Johnson - Member of Macroaxis Editorial Board

Be your own money manager

Tracking Abbott Laboratories inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.

Generate Optimal Portfolios

Align your risk and return expectations

By capturing risk tolerance and investment horizon, Macroaxis optimization evaluates acceptable risk for target return profiles. The process summarizes how much risk can be taken for a given return goal.

Fix portfolios for free

Additional Tools for Abbott Stock Analysis

	ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital
	Volatility Analysis Get historical volatility and risk analysis based on latest market data
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2026 Macroaxis LLC